摘要
目的:进行不同抗生素方案在下呼吸道感染治疗工作中的药学分析,为临床用药提供正确的指导。方法:选取收治的140例下呼吸道感染患者,根据不同的治疗方案分为4组,每组35例。接受头孢曲松钠治疗者定为观察组A,接受左氧氟沙星治疗者定为观察组B,接受头孢唑肟钠治疗者定为观察组C,接受阿奇霉素治疗者定为观察组D,观察并比较各组治疗效果及治疗成本。结果:观察组A、B、C、D患者临床疗效、不良反应发生率的差异对比均为P>0.05,无统计学意义,但观察组A(1021.4±12.8)元、B(1013.6±18.8)元的治疗成本显著低于观察组C和D(P<0.05)。结论:不同抗生素方案治疗下呼吸道感染均可获得较好疗效,头孢曲松钠、左氧氟沙星的治疗成本更低,具有较高的性价比,值得临床推广。
Objective：to analyze and evaluate the antibiotic regimen in the treatment of patients with different analysis work in the pharmacy of lower respiratory tract infection,provide correct guidance for clinical medicine. Methods：selected in our hospital 140 cases of patients with lower respiratory tract infection,according to the different treatment options which will be divided into 4 groups,each group had 35 cases,ceftriaxone sodium treatment as the observation group A,levofloxacin treatment as the observation group B,ceftizoxime sodium treatment as the observation group C,azithromycin treatment as the observation group D,observe and compare the therapeutic effect and cost of treatment group. Results：in the observation group,A,B,C,clinical efficacy,adverse reaction rate in patients with D compared the difference was P〉0.05 was not significant,but the observation group A（1021.4±12.8）yuan,B（1013.6±18.8）yuan of the cost of treatment was significantly lower than the observation group C and D（P〈0.05）. Conclusion：to obtain better curative effect can be different antibiotic regimens in the treatment of lower respiratory tract infection,which,at lower cost and treatment of ceftriaxone sodium,levofloxacin,has a high price,it is worth in clinical application.
出处
《北方药学》
2015年第3期150-151,共2页
Journal of North Pharmacy
关键词
下呼吸道感染
抗生素
药学分析
Lower respiratory tract infection
Antibiotics
Pharmaceutical analysis
